| Heterotrimeric Complex of Human ASCT2 with Syncytin-1 | |
Heteromer
Q9UQF0; | 43-489 | 100.0 | 2×ALA; |
|
| Complex of human ASCT2 with Syncytin-1 | |
Heteromer
Q9UQF0; | 43-488 | 100.0 | 2×ALA; |
|
| Structure of the human neutral amino acid transporter ASCT2 in complex with nanobody 469 | |
Heteromer
| 49-489 | 100.0 | 9×NA; 3×ALA; 3×Y01; |
|
| Structure of the thermostabilized EAAT1 cryst-II mutant in complex with L-ASP | | homo-3-mer | 50-498 | 100 | 3×NA; 3×ASP; |
|
| Inward-open structure of the ASCT2 (SLC1A5) mutant C467R in presence of TBOA | | homo-3-mer | 43-489 | 99.77 | |
|
| Inward-open structure of the ASCT2 (SLC1A5) mutant C467R in absence of substrate | | homo-3-mer | 43-489 | 99.77 | |
|
| cryo-EM structure of the human neutral amino acid transporter ASCT2 | | homo-3-mer | 43-489 | 100.0 | 3×GLN; |
|
| Cryo-EM structure of the human neutral amino acid transporter ASCT2 | | homo-3-mer | 43-488 | 100 | 3×NAG; |
|
| Cryo-EM structure of the human neutral amino acid transporter ASCT2 | | homo-3-mer | 43-488 | 100 | 3×GLN; 3×NAG; |
|
| ASCT2 in the presence of the inhibitor ERA-21 in the outward-open conformation. | | homo-3-mer | 47-488 | 100 | |
|
| ASCT2 in the presence of the inhibitor Lc-BPE (position "down") in the outward-open conformation. | | homo-3-mer | 47-488 | 100 | 3×TJ5; |
|
| ASCT2 in the presence of the inhibitor Lc-BPE (position "up") in the outward-open conformation. | | homo-3-mer | 47-488 | 100 | 3×TG2; |
|
| ASCT2 trimer in lipid nanodiscs with bound glutamine and Na+ ions in the outward-facing state (OFS) | | homo-3-mer | 49-487 | 100.0 | 9×NA; 3×GLN; |
|
| Structure of the thermostabilized EAAT1 cryst mutant in complex with L-ASP, three sodium ions and t… | | homo-3-mer | 50-480 | 100 | 9×NA; 3×ASP; 3×6Z6; 3×BA; |
|
| Structure of the thermostabilized EAAT1 cryst-E386Q mutant in complex with L-ASP, sodium ions and t… | | homo-3-mer | 50-480 | 100 | 6×NA; 3×ASP; 3×6Z6; 3×BA; |
|
| Structure of the thermostabilized EAAT1 cryst-II mutant in complex with barium and the allosteric i… | | homo-3-mer | 50-480 | 100 | 3×6Z6; 6×BA; |
|
| Structure of the thermostabilized EAAT1 cryst mutant in complex with the competititve inhibitor TFB… | | homo-3-mer | 50-480 | 100 | 3×6Z6; 3×7O9; |
|
| Structure of the thermostabilized EAAT1 cryst-II mutant in complex with rubidium and barium ions an… | | homo-3-mer | 50-480 | 100 | 3×6Z6; 6×BA; 3×RB; |
|
| Structure of the thermostabilized EAAT1 cryst mutant in complex with rubidium and barium and the al… | | homo-3-mer | 50-480 | 100 | 3×6Z6; 6×BA; 3×RB; |
|
| ASCT2 protomer in lipid nanodiscs with bound glutamine and Na+ ions in the outward-facing state (OF… | | monomer | 48-487 | 100.0 | 3×NA; 1×GLN; |
|
| ASCT2 protomer in lipid nanodiscs with bound glutamine and Na+ ions in the outward-facing state (OF… | | monomer | 48-487 | 100.0 | 3×NA; 1×GLN; |
|
| ASCT2 protomer in lipid nanodiscs with bound glutamine and Na+ ions in the outward-facing state (OF… | | monomer | 49-487 | 100.0 | 3×NA; 1×GLN; |
|
| ASCT2 protomer in lipid nanodiscs with bound glutamine and Na+ ions in the intermediate outward-fac… | | monomer | 49-487 | 100.0 | 1×GLN; |
|
| ASCT2 protomer in lipid nanodiscs under low Na+ concentration in the intermediate outward-facing st… | | monomer | 49-487 | 100.0 | 1×NA; |
|
| ASCT2 protomer in lipid nanodiscs with bound glutamine and Na+ ions in the intermediate outward-fac… | | monomer | 49-487 | 100.0 | 1×GLN; |
|
| ASCT2 protomer in lipid nanodiscs under low Na+ concentration in the outward-facing state (OFS) | | monomer | 49-487 | 100.0 | 1×NA; |
|
| Structure of the thermostalilized EAAT1 cryst-II mutant in complex with L-ASP and the allosteric in… | | monomer | 50-480 | 100 | 1×NA; 1×ASP; 1×6Z6; |
|
| Structure of the thermostabilized EAAT1 cryst mutant in complex with L-ASP and the allosteric inhib… | | monomer | 50-480 | 100 | 1×NA; 1×ASP; 1×6Z6; |
|